nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—ovarian follicle—ovarian cancer	0.0372	0.304	CbGeAlD
Ketorolac—PTGS1—oviduct—ovarian cancer	0.0171	0.14	CbGeAlD
Ketorolac—Tolmetin—CXCL8—ovarian cancer	0.00669	0.566	CrCbGaD
Ketorolac—PTGS2—myometrium—ovarian cancer	0.00523	0.0427	CbGeAlD
Ketorolac—PTGS2—embryo—ovarian cancer	0.00503	0.0411	CbGeAlD
Ketorolac—PTGS1—epithelium—ovarian cancer	0.0043	0.0351	CbGeAlD
Ketorolac—PTGS1—uterine cervix—ovarian cancer	0.00426	0.0348	CbGeAlD
Ketorolac—PTGS2—epithelium—ovarian cancer	0.00411	0.0335	CbGeAlD
Ketorolac—PTGS2—uterine cervix—ovarian cancer	0.00407	0.0332	CbGeAlD
Ketorolac—PTGS1—endometrium—ovarian cancer	0.00385	0.0315	CbGeAlD
Ketorolac—PTGS2—endometrium—ovarian cancer	0.00368	0.0301	CbGeAlD
Ketorolac—PTGS1—uterus—ovarian cancer	0.00355	0.029	CbGeAlD
Ketorolac—PTGS2—uterus—ovarian cancer	0.00339	0.0277	CbGeAlD
Ketorolac—Ketoprofen—CXCL8—ovarian cancer	0.00326	0.276	CrCbGaD
Ketorolac—PTGS1—female reproductive system—ovarian cancer	0.00319	0.0261	CbGeAlD
Ketorolac—PTGS2—female reproductive system—ovarian cancer	0.00305	0.0249	CbGeAlD
Ketorolac—PTGS1—female gonad—ovarian cancer	0.0029	0.0237	CbGeAlD
Ketorolac—PTGS1—vagina—ovarian cancer	0.00289	0.0236	CbGeAlD
Ketorolac—PTGS2—bone marrow—ovarian cancer	0.00288	0.0235	CbGeAlD
Ketorolac—PTGS2—female gonad—ovarian cancer	0.00278	0.0227	CbGeAlD
Ketorolac—PTGS2—vagina—ovarian cancer	0.00276	0.0225	CbGeAlD
Ketorolac—PTGS1—testis—ovarian cancer	0.00257	0.021	CbGeAlD
Ketorolac—Mebendazole—ABCB1—ovarian cancer	0.00187	0.158	CrCbGaD
Ketorolac—PTGS1—lymph node—ovarian cancer	0.00187	0.0152	CbGeAlD
Ketorolac—PTGS2—lymph node—ovarian cancer	0.00178	0.0146	CbGeAlD
Ketorolac—Decreased appetite—Paclitaxel—ovarian cancer	0.000449	0.000519	CcSEcCtD
Ketorolac—Dry mouth—Docetaxel—ovarian cancer	0.000447	0.000516	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000446	0.000515	CcSEcCtD
Ketorolac—Fatigue—Paclitaxel—ovarian cancer	0.000445	0.000514	CcSEcCtD
Ketorolac—Sweating—Epirubicin—ovarian cancer	0.000444	0.000513	CcSEcCtD
Ketorolac—Pollakiuria—Doxorubicin—ovarian cancer	0.000444	0.000513	CcSEcCtD
Ketorolac—Pain—Paclitaxel—ovarian cancer	0.000442	0.00051	CcSEcCtD
Ketorolac—Constipation—Paclitaxel—ovarian cancer	0.000442	0.00051	CcSEcCtD
Ketorolac—Haematuria—Epirubicin—ovarian cancer	0.000442	0.00051	CcSEcCtD
Ketorolac—Confusional state—Docetaxel—ovarian cancer	0.000442	0.00051	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000439	0.000507	CcSEcCtD
Ketorolac—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000438	0.000506	CcSEcCtD
Ketorolac—Oedema—Docetaxel—ovarian cancer	0.000438	0.000506	CcSEcCtD
Ketorolac—Anaphylactic shock—Docetaxel—ovarian cancer	0.000438	0.000506	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—ovarian cancer	0.000437	0.000505	CcSEcCtD
Ketorolac—Epistaxis—Epirubicin—ovarian cancer	0.000437	0.000505	CcSEcCtD
Ketorolac—Infection—Docetaxel—ovarian cancer	0.000435	0.000503	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000434	0.000501	CcSEcCtD
Ketorolac—Agranulocytosis—Epirubicin—ovarian cancer	0.000432	0.000499	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—ovarian cancer	0.000431	0.000498	CcSEcCtD
Ketorolac—Shock—Docetaxel—ovarian cancer	0.000431	0.000498	CcSEcCtD
Ketorolac—Nervous system disorder—Docetaxel—ovarian cancer	0.000429	0.000496	CcSEcCtD
Ketorolac—Thrombocytopenia—Docetaxel—ovarian cancer	0.000429	0.000495	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—ovarian cancer	0.000428	0.000495	CcSEcCtD
Ketorolac—Tachycardia—Docetaxel—ovarian cancer	0.000427	0.000494	CcSEcCtD
Ketorolac—Feeling abnormal—Paclitaxel—ovarian cancer	0.000426	0.000492	CcSEcCtD
Ketorolac—Skin disorder—Docetaxel—ovarian cancer	0.000425	0.000491	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000425	0.000491	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—ovarian cancer	0.000423	0.000489	CcSEcCtD
Ketorolac—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000422	0.000488	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—ovarian cancer	0.000421	0.000487	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—ovarian cancer	0.000418	0.000483	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—ovarian cancer	0.000418	0.000482	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—ovarian cancer	0.000418	0.000482	CcSEcCtD
Ketorolac—Anorexia—Docetaxel—ovarian cancer	0.000417	0.000482	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—ovarian cancer	0.000417	0.000481	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—ovarian cancer	0.000417	0.000481	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—ovarian cancer	0.000416	0.00048	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—ovarian cancer	0.000416	0.00048	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—ovarian cancer	0.000411	0.000475	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—ovarian cancer	0.000411	0.000474	CcSEcCtD
Ketorolac—Urticaria—Paclitaxel—ovarian cancer	0.00041	0.000474	CcSEcCtD
Ketorolac—Hypotension—Docetaxel—ovarian cancer	0.000409	0.000473	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—ovarian cancer	0.000409	0.000472	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—ovarian cancer	0.000409	0.000472	CcSEcCtD
Ketorolac—Abdominal pain—Paclitaxel—ovarian cancer	0.000408	0.000472	CcSEcCtD
Ketorolac—Body temperature increased—Paclitaxel—ovarian cancer	0.000408	0.000472	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—ovarian cancer	0.000408	0.000471	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000405	0.000468	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—ovarian cancer	0.000404	0.000467	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—ovarian cancer	0.000401	0.000463	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—ovarian cancer	0.0004	0.000462	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000399	0.000461	CcSEcCtD
Ketorolac—Insomnia—Docetaxel—ovarian cancer	0.000396	0.000457	CcSEcCtD
Ketorolac—Paraesthesia—Docetaxel—ovarian cancer	0.000393	0.000454	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—ovarian cancer	0.000393	0.000454	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—ovarian cancer	0.000392	0.000452	CcSEcCtD
Ketorolac—Dyspnoea—Docetaxel—ovarian cancer	0.00039	0.000451	CcSEcCtD
Ketorolac—Somnolence—Docetaxel—ovarian cancer	0.000389	0.00045	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—ovarian cancer	0.000389	0.000449	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—ovarian cancer	0.000388	0.000448	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—ovarian cancer	0.000387	0.000447	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—ovarian cancer	0.000386	0.000446	CcSEcCtD
Ketorolac—Flushing—Epirubicin—ovarian cancer	0.000386	0.000446	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—ovarian cancer	0.000386	0.000445	CcSEcCtD
Ketorolac—Dyspepsia—Docetaxel—ovarian cancer	0.000385	0.000445	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—ovarian cancer	0.000385	0.000444	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—ovarian cancer	0.000385	0.000444	CcSEcCtD
Ketorolac—Decreased appetite—Docetaxel—ovarian cancer	0.000381	0.00044	CcSEcCtD
Ketorolac—Hypersensitivity—Paclitaxel—ovarian cancer	0.000381	0.00044	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00038	0.000439	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000378	0.000437	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000378	0.000437	CcSEcCtD
Ketorolac—Fatigue—Docetaxel—ovarian cancer	0.000378	0.000436	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—ovarian cancer	0.000377	0.000436	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—ovarian cancer	0.000377	0.000436	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—ovarian cancer	0.000376	0.000434	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—ovarian cancer	0.000375	0.000433	CcSEcCtD
Ketorolac—Pain—Docetaxel—ovarian cancer	0.000374	0.000433	CcSEcCtD
Ketorolac—Constipation—Docetaxel—ovarian cancer	0.000374	0.000433	CcSEcCtD
Ketorolac—Chills—Epirubicin—ovarian cancer	0.000373	0.000431	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—ovarian cancer	0.000371	0.000429	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—ovarian cancer	0.000371	0.000428	CcSEcCtD
Ketorolac—Asthenia—Paclitaxel—ovarian cancer	0.000371	0.000428	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—ovarian cancer	0.000367	0.000424	CcSEcCtD
Ketorolac—Pruritus—Paclitaxel—ovarian cancer	0.000366	0.000422	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—ovarian cancer	0.000364	0.000421	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—ovarian cancer	0.000364	0.00042	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—ovarian cancer	0.000362	0.000418	CcSEcCtD
Ketorolac—Erythema—Epirubicin—ovarian cancer	0.000362	0.000418	CcSEcCtD
Ketorolac—Feeling abnormal—Docetaxel—ovarian cancer	0.000361	0.000417	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—ovarian cancer	0.000359	0.000415	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—ovarian cancer	0.000359	0.000414	CcSEcCtD
Ketorolac—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000358	0.000414	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—ovarian cancer	0.000357	0.000412	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—ovarian cancer	0.000357	0.000412	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—ovarian cancer	0.000357	0.000412	CcSEcCtD
Ketorolac—Tension—Epirubicin—ovarian cancer	0.000355	0.00041	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—ovarian cancer	0.000354	0.000409	CcSEcCtD
Ketorolac—Diarrhoea—Paclitaxel—ovarian cancer	0.000353	0.000408	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—ovarian cancer	0.000351	0.000406	CcSEcCtD
Ketorolac—Back pain—Epirubicin—ovarian cancer	0.00035	0.000404	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—ovarian cancer	0.000349	0.000403	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—ovarian cancer	0.000347	0.000401	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000347	0.0004	CcSEcCtD
Ketorolac—Abdominal pain—Docetaxel—ovarian cancer	0.000346	0.0004	CcSEcCtD
Ketorolac—Body temperature increased—Docetaxel—ovarian cancer	0.000346	0.0004	CcSEcCtD
Ketorolac—Chills—Doxorubicin—ovarian cancer	0.000345	0.000399	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—ovarian cancer	0.000344	0.000397	CcSEcCtD
Ketorolac—Dizziness—Paclitaxel—ovarian cancer	0.000342	0.000395	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—ovarian cancer	0.000341	0.000394	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—ovarian cancer	0.00034	0.000393	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—ovarian cancer	0.000337	0.000389	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—ovarian cancer	0.000336	0.000388	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—ovarian cancer	0.000335	0.000387	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—ovarian cancer	0.000335	0.000387	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—ovarian cancer	0.000334	0.000386	CcSEcCtD
Ketorolac—Agitation—Epirubicin—ovarian cancer	0.000333	0.000384	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—ovarian cancer	0.00033	0.000381	CcSEcCtD
Ketorolac—Tension—Doxorubicin—ovarian cancer	0.000329	0.00038	CcSEcCtD
Ketorolac—Vomiting—Paclitaxel—ovarian cancer	0.000328	0.000379	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—ovarian cancer	0.000328	0.000379	CcSEcCtD
Ketorolac—Malaise—Epirubicin—ovarian cancer	0.000326	0.000377	CcSEcCtD
Ketorolac—Rash—Paclitaxel—ovarian cancer	0.000326	0.000376	CcSEcCtD
Ketorolac—Dermatitis—Paclitaxel—ovarian cancer	0.000325	0.000376	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—ovarian cancer	0.000325	0.000376	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—ovarian cancer	0.000325	0.000376	CcSEcCtD
Ketorolac—Syncope—Epirubicin—ovarian cancer	0.000325	0.000375	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—ovarian cancer	0.000324	0.000374	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—ovarian cancer	0.000324	0.000374	CcSEcCtD
Ketorolac—Headache—Paclitaxel—ovarian cancer	0.000324	0.000374	CcSEcCtD
Ketorolac—Hypersensitivity—Docetaxel—ovarian cancer	0.000323	0.000373	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—ovarian cancer	0.00032	0.000369	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—ovarian cancer	0.000318	0.000367	CcSEcCtD
Ketorolac—Cough—Epirubicin—ovarian cancer	0.000316	0.000365	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—ovarian cancer	0.000316	0.000365	CcSEcCtD
Ketorolac—Asthenia—Docetaxel—ovarian cancer	0.000314	0.000363	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—ovarian cancer	0.000314	0.000362	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—ovarian cancer	0.000312	0.000361	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000311	0.000359	CcSEcCtD
Ketorolac—Pruritus—Docetaxel—ovarian cancer	0.00031	0.000358	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—ovarian cancer	0.000309	0.000358	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—ovarian cancer	0.000308	0.000356	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—ovarian cancer	0.000308	0.000356	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—ovarian cancer	0.000308	0.000356	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—ovarian cancer	0.000308	0.000355	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—ovarian cancer	0.000307	0.000355	CcSEcCtD
Ketorolac—Nausea—Paclitaxel—ovarian cancer	0.000307	0.000354	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000306	0.000353	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—ovarian cancer	0.000304	0.000352	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—ovarian cancer	0.000302	0.000349	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—ovarian cancer	0.000301	0.000348	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—ovarian cancer	0.000301	0.000348	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—ovarian cancer	0.0003	0.000347	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—ovarian cancer	0.0003	0.000346	CcSEcCtD
Ketorolac—Diarrhoea—Docetaxel—ovarian cancer	0.0003	0.000346	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—ovarian cancer	0.000298	0.000344	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—ovarian cancer	0.000296	0.000342	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—ovarian cancer	0.000295	0.000341	CcSEcCtD
Ketorolac—Oedema—Epirubicin—ovarian cancer	0.000295	0.000341	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—ovarian cancer	0.000294	0.00034	CcSEcCtD
Ketorolac—Infection—Epirubicin—ovarian cancer	0.000293	0.000339	CcSEcCtD
Ketorolac—Cough—Doxorubicin—ovarian cancer	0.000292	0.000338	CcSEcCtD
Ketorolac—Shock—Epirubicin—ovarian cancer	0.000291	0.000336	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—ovarian cancer	0.00029	0.000335	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—ovarian cancer	0.00029	0.000335	CcSEcCtD
Ketorolac—Dizziness—Docetaxel—ovarian cancer	0.00029	0.000334	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—ovarian cancer	0.000289	0.000334	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—ovarian cancer	0.000289	0.000334	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—ovarian cancer	0.000288	0.000333	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—ovarian cancer	0.000287	0.000331	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—ovarian cancer	0.000286	0.00033	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—ovarian cancer	0.000285	0.000329	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—ovarian cancer	0.000285	0.000329	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—ovarian cancer	0.000285	0.000329	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—ovarian cancer	0.000284	0.000328	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000283	0.000327	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—ovarian cancer	0.000282	0.000325	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—ovarian cancer	0.000282	0.000325	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—ovarian cancer	0.000279	0.000322	CcSEcCtD
Ketorolac—Vomiting—Docetaxel—ovarian cancer	0.000278	0.000322	CcSEcCtD
Ketorolac—Rash—Docetaxel—ovarian cancer	0.000276	0.000319	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—ovarian cancer	0.000276	0.000319	CcSEcCtD
Ketorolac—Dermatitis—Docetaxel—ovarian cancer	0.000276	0.000319	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—ovarian cancer	0.000276	0.000318	CcSEcCtD
Ketorolac—Headache—Docetaxel—ovarian cancer	0.000274	0.000317	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—ovarian cancer	0.000273	0.000316	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000273	0.000316	CcSEcCtD
Ketorolac—Infection—Doxorubicin—ovarian cancer	0.000272	0.000314	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000269	0.000311	CcSEcCtD
Ketorolac—Shock—Doxorubicin—ovarian cancer	0.000269	0.000311	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—ovarian cancer	0.000268	0.00031	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000268	0.000309	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—ovarian cancer	0.000267	0.000309	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—ovarian cancer	0.000267	0.000308	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—ovarian cancer	0.000265	0.000307	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—ovarian cancer	0.000265	0.000306	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000264	0.000305	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—ovarian cancer	0.000263	0.000304	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—ovarian cancer	0.000263	0.000303	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—ovarian cancer	0.000261	0.000301	CcSEcCtD
Ketorolac—Nausea—Docetaxel—ovarian cancer	0.00026	0.0003	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—ovarian cancer	0.00026	0.0003	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—ovarian cancer	0.000257	0.000297	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—ovarian cancer	0.000255	0.000295	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000255	0.000295	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—ovarian cancer	0.000255	0.000294	CcSEcCtD
Ketorolac—Pain—Epirubicin—ovarian cancer	0.000253	0.000292	CcSEcCtD
Ketorolac—Constipation—Epirubicin—ovarian cancer	0.000253	0.000292	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000249	0.000288	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—ovarian cancer	0.000247	0.000286	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—ovarian cancer	0.000245	0.000283	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—ovarian cancer	0.000244	0.000281	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—ovarian cancer	0.000243	0.000281	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—ovarian cancer	0.000243	0.000281	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000242	0.000279	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—ovarian cancer	0.000241	0.000278	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—ovarian cancer	0.000238	0.000274	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000236	0.000273	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—ovarian cancer	0.000236	0.000272	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—ovarian cancer	0.000235	0.000271	CcSEcCtD
Ketorolac—Pain—Doxorubicin—ovarian cancer	0.000234	0.00027	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—ovarian cancer	0.000234	0.00027	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—ovarian cancer	0.000233	0.00027	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—ovarian cancer	0.000233	0.00027	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—ovarian cancer	0.000225	0.00026	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000223	0.000258	CcSEcCtD
Ketorolac—Hypersensitivity—Epirubicin—ovarian cancer	0.000218	0.000251	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—ovarian cancer	0.000217	0.000251	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—ovarian cancer	0.000216	0.00025	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—ovarian cancer	0.000216	0.00025	CcSEcCtD
Ketorolac—Asthenia—Epirubicin—ovarian cancer	0.000212	0.000245	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—ovarian cancer	0.000209	0.000241	CcSEcCtD
Ketorolac—Diarrhoea—Epirubicin—ovarian cancer	0.000202	0.000233	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—ovarian cancer	0.000201	0.000233	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—ovarian cancer	0.000196	0.000226	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—ovarian cancer	0.000195	0.000226	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—ovarian cancer	0.000193	0.000223	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—ovarian cancer	0.000188	0.000217	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—ovarian cancer	0.000187	0.000216	CcSEcCtD
Ketorolac—Rash—Epirubicin—ovarian cancer	0.000186	0.000215	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—ovarian cancer	0.000186	0.000215	CcSEcCtD
Ketorolac—Headache—Epirubicin—ovarian cancer	0.000185	0.000214	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—ovarian cancer	0.000181	0.000209	CcSEcCtD
Ketorolac—Nausea—Epirubicin—ovarian cancer	0.000175	0.000203	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—ovarian cancer	0.000174	0.000201	CcSEcCtD
Ketorolac—Rash—Doxorubicin—ovarian cancer	0.000172	0.000199	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—ovarian cancer	0.000172	0.000199	CcSEcCtD
Ketorolac—Headache—Doxorubicin—ovarian cancer	0.000171	0.000198	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—ovarian cancer	0.000162	0.000188	CcSEcCtD
